GSK And Singapore's Economic Development Board Finance Asian Public Health Research Through Public-Private Fund
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - The National University of Singapore has set up an initiative to advance public health and healthcare delivery in Asia. The 10-year initiative will be funded with S$17 million ($12.3 million) from the GSK-EDB Trust Fund, a joint fund created by GlaxoSmithKline and Singapore's Economic Development Board